呼吸吸入器市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00003093
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 254
Buy Now

呼吸吸入器市场预计将从2022年的311.4456亿美元增长到2028年的434.4619亿美元;预计 2022 年至 2028 年间复合年增长率为 5.7%。

呼吸吸入器用于吸入药物,这是治疗慢性肺部疾病的重要组成部分。它们用于预防和治疗这些慢性疾病的恶化。它们的优点是避免全身药物暴露,同时确保药物直接到达肺部。许多产品将药物直接输送到气道中,例如干粉吸入器、定量吸入器 (MDI)、雾化器和软雾吸入器。由于哮喘、慢性阻塞性肺病(COPD)、囊性纤维化、哮喘-COPD重叠综合征等呼吸系统疾病的患病率不断上升,呼吸吸入器市场预计将增长。

战略展望

呼吸吸入器市场前景

通用吸入器的采用不断增加推动呼吸吸入器市场增长

涉及各种吸入装置的吸入药物是药理学策略的支柱用于治疗哮喘和慢性阻塞性肺病。哮喘和慢性阻塞性肺病患者通常每天需要一个或多个吸入器以保持呼吸道健康。因此,医疗保健专业人员担心药物之间的转换,因为由于依从性差和误用气雾剂输送设备类型,这可能会对疾病控制产生负面影响。随着医疗保健预算压力的增加以及现有吸入疗法专利的同时到期,世界各地正在生产和供应多种仿制药替代产品。用于治疗哮喘的各种吸入剂包括通用制剂,例如沙丁胺醇、左沙丁胺醇、异丙托铵、布地奈德和氟替卡松/沙美特罗。普通吸入器与品牌吸入器具有生物等效性,并且对身体具有相同的效果。随着专利到期,非专利哮喘吸入器的数量持续增加。 2020 年 3 月 3 日,美国食品和药物管理局 (FDA) 批准了仿制药哮喘吸入器和仿制药粉状吸入皮质类固醇。 2020年4月,FDA批准了一种基于硫酸沙丁胺醇的仿制药吸入器,以满足呼吸困难的COVID-19患者的需求。随着更多的仿制药进入市场,预计竞争将更加激烈,从而导致药品成本下降。推出“批准的仿制药”也可能导致成本降低。因此,越来越多地采用仿制药吸入器和哮喘药物正在提高用药依从性,从而推动呼吸吸入器市场的发展。

基于产品类型的信息

< p>基于产品类型,呼吸药物吸入器市场分为雾化器、定量吸入器和干粉吸入器。干粉吸入器细分市场进一步分为多剂量干粉吸入器和单剂量干粉吸入器。计量吸入器(MDI)部分进一步分为加压计量吸入器和连接式计量吸入器。雾化器细分为压缩空气雾化器、网状空气雾化器和超声波空气雾化器。 2022年,干粉吸入器领域占据最大的市场份额。然而,预计计量吸入器 (MDI) 领域在预测期内的复合年增长率最高。

呼吸吸入器市场,按产品类型划分:2022 年和 2028 年

基于技术洞察

根据技术,呼吸吸入器市场分为手动操作吸入器和数字操作吸入器。手动操作吸入器细分市场将在 2022 年占据较高的市场份额,预计在预测期内将实现更高的复合年增长率。

基于疾病适应症的信息

根据疾病,全球呼吸吸入器市场分为哮喘、慢性阻塞性肺病、肺动脉高压等。哮喘细分市场在 2022 年占据最大的市场份额,预计在预测期内将以最高复合年增长率增长。

呼吸吸入器市场的公司广泛采用无机和有机策略,例如并购。以下列出了市场近期的一些关键进展:

  • 2022 年 9 月,Beximco Pharmaceuticals 推出了 ONRIVA TRIO BEXICAP,这是一种干吸入器胶囊。 ONRIVA TRIO BEXICAP 是茚达特罗 (150 µg)、格隆铵 (50 µg) 和莫米松 (160 µg) 的制剂。它通过 3 种方式发挥作用来控制哮喘症状。茚达特罗和格隆铵有助于保持肺气道肌肉放松,以防止支气管收缩,而莫米松则有助于减少炎症。 ONRIVA TRIO BEXICAP 适用于严重持续性哮喘的维持治疗。
  • 2021 年 6 月,Cipla 宣布其酒石酸阿福特罗吸入溶液 15 mcg/ 的简化新药申请 (ANDA) 已获得最终批准2. mL,来自美国食品和药物管理局。Cipla Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL 是 Sunovion Pharmaceuticals Inc. 生产的 Brovana 的 AN 级仿制药治疗版本。
  • 2022 年 2 月,阿斯利康和霍尼韦尔宣布了合作开发计划。使用推进剂 HFO-1234ze 的下一代呼吸吸入器,其全球变暖潜能值 (GWP) 比目前呼吸系统药物中使用的推进剂低 99.9%。
  • 2023 年 1 月,FDA 批准了 Airsupra [加压定量吸入器(pMDI)]在美国用于按需治疗或预防支气管收缩。 Airsupra 是一款一流的加压计量吸入器 (pMDI),是一种固定剂量组合救援药物,含有沙丁胺醇、一种短效 β2 激动剂 (SABA) 和布地奈德,一种抗炎吸入皮质类固醇 (ICS)。在美国

公司简介

  • 阿斯利康公司
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • GSK Plc
  • Koninklijke Philips NV
  • 欧姆龙公司
  • PARI Respiratory Equipment, Inc .
  • 梯瓦制药工业有限公司
  • OPKO Health, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the respiratory inhalers market?

Respiratory inhalers are used to inhale drugs that are an essential part of treating chronic lung diseases. They are used both to prevent and treat exacerbations of these chronic diseases. They offer the advantage of avoiding systemic drug exposure while ensuring the drugs reach the lungs directly. Numerous products deliver drugs directly into the airways, such as dry powder inhalers, metered dose inhalers (MDIs), nebulizers and soft mist inhalers. The respiratory inhaler market is expected to flourish due to the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma-COPD overlap syndrome, and others.

What are the driving factors for the respiratory inhalers market across the globe?

Key factors driving the market growth are rising cases of respiratory disorders and growing adoption of generic inhalers.

Which segment led the respiratory inhalers market?

The respiratory inhalers market, by product type, is segmented into nebulizers, metered dose inhalers, and dry powder inhalers. The dry powder inhalers segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period (2022–2028).

Which technology segment held the largest revenue (US$ Mn) in the respiratory inhalers market?

Based on technology, the global respiratory inhalers market is divided into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period.

Who are the key players in the respiratory inhalers market?

Companies operating in the market are AstraZeneca Plc, Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH, Cipla Ltd.;GSK Plc, Koninklijke Philips NV, OMRON Corp, PARI Respiratory Equipment, Inc.; Teva Pharmaceutical Industries Ltd.; and OPKO Health, Inc..

What is the regional market scenario of the respiratory inhalers market?

Global respiratory inhalers market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the respiratory inhalers market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

The List of Companies - Respiratory Inhalers Market

  1. AstraZeneca Plc
  2. Beximco Pharmaceuticals Ltd.
  3. Boehringer Ingelheim International GmbH
  4. Cipla Ltd.
  5. GSK Plc
  6. Koninklijke Philips NV
  7. OMRON Corp
  8. PARI Respiratory Equipment, Inc.
  9. Teva Pharmaceutical Industries Ltd.
  10. OPKO Health, Inc.  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports